Menu

Clinical trials showing promise in treating gynecologic cancers

When Dianne Burch was diagnosed with ovarian cancer, she was unsure of what the outcome may be. Today, she is in full remission from her disease and is currently enrolled in a clinical research trial at Willamette Valley Cancer Institute in Eugene, one of five trials underway focusing on gynecologic cancers.

By | February 12th, 2019|Blog, GYN Cancers, Targeting Cancer|

The benefits of exercise

Cancer survivors are often told that exercise is beneficial to their recovery, but the reality of getting active or working out when you're dealing with debilitating side effects is difficult—and knowing where to start can be overwhelming. The LIVESTRONG at the YMCA program gives cancer survivors the tools to get started and the support to keep going.

By | January 30th, 2019|Blog, Targeting Cancer|

Proceeds from Argentine tango classes support local cancer patients

Charles and Wella Augustine have been doing the Argentine tango since they met at a social dance seven years ago. Now, they teach community classes for beginning, intermediate and advanced students, and they donate the proceeds to Oregon Cancer Foundation, providing financial assistance to cancer patients in Lane County.

By | December 7th, 2018|Blog, Targeting Cancer|

How to handle the holidays during cancer treatment

Laura Bunsen of Albany, Oregon loves the holidays and all the traditions. But when she was diagnosed with multiple myeloma, the holidays were tough. She didn't have the energy to do all the things she had done before and that frustrated her. Laura shares how she learned to be OK with doing less and now focuses on what matters most to her.

By | December 4th, 2018|Targeting Cancer|

Robotic surgery offers less invasive treatment of gynecologic cancers

The FDA approved robotic technology for gynecologic surgeries in 2006. Dr. Audrey Garrett, Dr. Charles Anderson and Dr. Kathleen Yang at Willamette Valley Cancer Institute are the only gynecologic oncologists between Sacramento and Portland on the I-5 corridor using this technology. Between them, they have performed almost 3,000 surgical procedures.

By | November 6th, 2018|Blog, Targeting Cancer|

Clinical trials changing the treatment playbook for patients

Clinical research trials are revealing much more about individual cancer cells—what makes them change and grow and how to shut them down; however, less than five percent of eligible adult cancer patients participate in trials. Michael Heer of Eugene credits ongoing research to giving him more options to manage his cancer, and more time with his family.

By | October 23rd, 2018|Blog, Targeting Cancer|
Load More Posts